Product Information
FLUTICASONE-SALMETEROL 55-14 is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $111.4357 per EA under NDC 00093360782. Its NADAC has been published 428 times since Apr 18, 2018.
Strength
55; 14 ug/1; ug/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093360782
Classification
Generic
Dosage Form
POWDER, METERED
Route
RESPIRATORY (INHALATION)
Last Updated
6/17/2026
Active Ingredients
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA208799On Market Since
4/28/2017
Pharmacological Classes
Price Statistics
The NADAC for FLUTICASONE-SALMETEROL 55-14 has been published 428 times since Apr 18, 2018, and over the history we have for it it has risen 23.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $111.4357 per EA |
|---|---|
| All-time high | $111.4357 (Jun 24, 2026) |
| All-time low | $83.3740 (Jan 23, 2019) |
| 52-week high | $111.4357 |
| 52-week low | $106.9124 |
| Median price | $97.7800 |
| Average price | $97.7587 |
| Largest weekly change | +21.0% (Apr 20, 2022) |
| Weeks tracked | 428 |
| Tracking since | Apr 18, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Fluticasone Propionate and Salmeterol market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of FLUTICASONE-SALMETEROL 55-14?
The current National Average Drug Acquisition Cost (NADAC) for FLUTICASONE-SALMETEROL 55-14, manufactured by Teva Pharmaceuticals USA Inc., is $111.4357 per EA (NDC 00093360782), effective Jun 24, 2026.
How has the price of FLUTICASONE-SALMETEROL 55-14 changed over time?
Over the history we have for it, the NADAC for FLUTICASONE-SALMETEROL 55-14 has risen 23.2%. It has been tracked across 428 weekly CMS publications since Apr 18, 2018.
What are the highest and lowest recorded NADAC prices for FLUTICASONE-SALMETEROL 55-14?
Since Apr 18, 2018, the NADAC for FLUTICASONE-SALMETEROL 55-14 has ranged from a low of $83.3740 (Jan 23, 2019) to a high of $111.4357 (Jun 24, 2026), with a median of $97.7800 per EA.
Are there cheaper alternatives to FLUTICASONE-SALMETEROL 55-14?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of FLUTICASONE-SALMETEROL 55-14, so no direct lower-cost alternative is listed.
Who manufactures FLUTICASONE-SALMETEROL 55-14?
FLUTICASONE-SALMETEROL 55-14 (NDC 00093360782) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification